| abstract |
The invention relates to bicyclic heterocycle derivatives, compositions comprising bicyclic heterocycle derivatives, and to treat or prevent obesity, diabetes, metabolic disorders, cardiovascular diseases or GPR119 activity related disorders in patients. The present invention relates to a method using a cyclic heterocyclic derivative. Compounds of formula (I), (II), (III) and (IV) and their pharmaceutically acceptable salts, solvates, esters or prodrugs (herein referred to as “bicyclic heterocyclic derivatives”) Can be useful for treating or preventing obesity, diabetes, diabetic complications, metabolic syndrome, cardiovascular disease or GPR119 activity-related disorders (each of which is a “medical condition”) in a patient. . |